EGFR and glioblastoma: The collective influence of RTK signalling on cell motility and invasion was validated with our observations, showing that, both in primary patient-derived cells and in established GBM cell lines, inhibition of RTKs, including EGFR, PDGFR, VEGFR and c-Met, promoted a clear reduction in both cell motility and invasion.